Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic PlaqueZsófia D. Drobni, Tomas G. Neilan, Sean Murphy et al.|Circulation|2020Cited by 535
Activin type II receptor signaling in cardiac aging and heart failureJason D. Roh, Anthony Rosenzweig, Ryan Hobson et al.|Science Translational Medicine|2019Cited by 147